bioAffinity Technologies (BIAF) EBITDA Margin (2022 - 2026)
bioAffinity Technologies (BIAF) posted quarterly EBITDA Margin of 265.82% for Q1 2026, down 12644.0% YoY from N/an in Q1 2025, and down 36.6% sequentially from 194.59% in Q4 2025.
bioAffinity Technologies (BIAF) EBITDA Margin (2022 - 2026) Analysis & Trends
bioAffinity Technologies has disclosed EBITDA Margin across 5 years of filings, most recently posting 265.82% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 12644.0% year-over-year to 265.82%; the TTM figure through Mar 2026 stood at 201.62% (down 9414.0% YoY), while the FY2025 annual figure was 168.81%, down 7491.0% from the prior year.
- EBITDA Margin declined to 265.82% in Q1 2026, from 194.59% in the prior quarter.
- Over the last five years, EBITDA Margin for BIAF reached as high as 79.22% in Q1 2024 and fell as low as 166806.19% in Q1 2023.
- The 5-year median for EBITDA Margin is 194.62% (2025), against an average of 23999.31%.
- Annual changes were most pronounced in 2024 — EBITDA Margin soared 16672697 bps — and 2026, when it slumped 12644 bps.
- A 5-year view of EBITDA Margin shows it stood at 68902.77% in 2022, then surged by 100 bps to 98.32% in 2023, then plunged by 34 bps to 131.53% in 2024, then plunged by 48 bps to 194.59% in 2025, then tumbled by 37 bps to 265.82% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 265.82%, 194.59%, and 155.47% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 31.78% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -12.21% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 21.74% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 12.38% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 19.42% |
| 10 | bioAffinity Technologies | 3.78 Mn | 675,591.56 | - | -265.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -265.82% |
| Dec 31, 2025 | -194.59% |
| Sep 30, 2025 | -155.47% |
| Jun 30, 2025 | -194.65% |
| Mar 31, 2025 | -139.37% |
| Dec 31, 2024 | -131.53% |
| Sep 30, 2024 | -82.26% |
| Jun 30, 2024 | -85.40% |
| Mar 31, 2024 | -79.22% |
| Dec 31, 2023 | -98.32% |
| Sep 30, 2023 | -753.61% |
| Jun 30, 2023 | -8,903.38% |
| Mar 31, 2023 | -166,806.19% |
| Dec 31, 2022 | -68,902.77% |
| Sep 30, 2022 | -84,813.57% |
| Jun 30, 2022 | -52,382.77% |